typo on last post be*
yesterday's statement did say;
VR040 (Parkinson's disease) - Phase II "at home" study clinical phase complete; results expected in 2010. Vectura is seeking a licensing partner
or could there be an up date on the VR315??
Pretty much as expected. It will be interesting to see the result for the VR040 (Parkinson's disease) this year.
Another 12 months i think and we should see the true value of vectura.
I've been keeping an eye out for KLG for a few weeks now since reading Gedw posts. I have most of my money tied up ( in HAWK VEC PCI NTG and a few others) but might be able to get a couple of k's on my isa.